A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

NCT07276997 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Icalcaprant
DRUG: Placebo for Icalcaprant

Sponsor

AbbVie